Skip to Content


The Office of Cancer Clinical Proteomics Research (OCCPR) promotes the sharing and dissemination of laboratory tested technologies and reagents to benefit and promote research across the world.  To this regard, several key resources (i.e. data, software tools, reagents, biospecimens and documents) have been developed in OCCPR's initiatives have been made publicly available :

  • Mouse Biorepository: provides samples remaining from the Mouse Proteomic Technologies Initiative
  • Software Tools: developed from previous funding
  • Regulatory Science: peer-reviewed journal articles exploring the regulatory nature of proteomics in coordination with the Food and Drug Administration,
  • Open Data Policy: highlights efforts and articles that are working towards the open distribution of research data.

In addition to these resources and tools, the Antibody Portal houses over 190 monoclonal antibodies developed against 69 different antigens.  Each of these antibodies is publicly available via dual distribution mechanisms (academia/industry), all of which have been well-characterized with  standard operating procedures and data related to each characterization procedure.

Launch Antibody Portal »

The Antibody Portal serves as a public resource of well-characterized monoclonal antibodies made available by the NCI for the scientific community.

Launch Data Portal »

The Clinical Proteomic Tumor Analysis Consortium (CPTAC) Data Portal provides a platform for researchers to search, download, and analyze data sets generated by CPTAC.